Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Revenue (2019 - 2025)

Volitionrx's Revenue history spans 9 years, with the latest figure at $362379.0 for Q4 2025.

  • For Q4 2025, Revenue rose 89.08% year-over-year to $362379.0; the TTM value through Dec 2025 reached $1.6 million, up 39.06%, while the annual FY2025 figure was $1.3 million, 3.49% up from the prior year.
  • Revenue reached $362379.0 in Q4 2025 per VNRX's latest filing, down from $538381.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $538381.0 in Q3 2025 to a low of $14240.0 in Q4 2021.
  • Average Revenue over 5 years is $192149.2, with a median of $168373.0 recorded in 2023.
  • Peak YoY movement for Revenue: surged 8298.03% in 2021, then dropped 21.44% in 2024.
  • A 5-year view of Revenue shows it stood at $14240.0 in 2021, then surged by 740.7% to $119715.0 in 2022, then surged by 103.79% to $243973.0 in 2023, then fell by 21.44% to $191657.0 in 2024, then soared by 89.08% to $362379.0 in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Revenue are $362379.0 (Q4 2025), $538381.0 (Q3 2025), and $406688.0 (Q2 2025).